While Dobbs purported to leave decisions about access to the states, a new frontier of litigation has emerged around the Food and Drug Administration's authority to facilitate and expand access to mifepristone, one of the drugs most commonly used for abortion in the United States.

Our expert panel gives an overview of the major lawsuits surrounding access to and use of mifepristone, with special attention to paths the Supreme Court may take to resolve these disputes in the near future.

SPEAKERS

• Susanna S. Birdsong, Planned Parenthood South Atlantic, Raleigh
• Carrie Flaxman, Democracy Forward, Washington, DC
• Muneeba Talukder, ACLU of North Carolina Legal Foundation, Raleigh (Moderator)

PRODUCED
Session from 2023 Constitutional Rights & Responsibilities Section Program, December 7, 2023

APPROVED CREDIT
North Carolina: 1.00 MCLE Hour

PROGRAM PRICING
See pricing below.

Access to the program and content expires ninety (90) days from the date of purchase.